Resources designed for you in your practice
OPTIMUM Phase III Study Profile
The efficacy and safety results from the OPTIMUM study,
a Phase III superiority study of PONVORY® vs teriflunomide
in patients with RMS
PONVORY® Information Booklet
An overview of PONVORY® that can aid
in your treatment decisions for patients
with RMS
CAN'T FIND WHAT YOU'RE LOOKING FOR?
We would be happy to assist you.
DISCOVER the convenience and flexibility of PONVORY®
SEE overall rates of treatment emergent adverse events vs teriflunomide from OPTIMUM
FIND OUT more about how PONVORY® works
RMS=relapsing multiple sclerosis
Contact your local Janssen Account Manager
Request Medical Information
Stay in Touch with Janssen
